Bangalore 26-December-2022 : Sami-Sabinsa Group Ltd. recently unveiled the book on Selenium, a mineral that has been extensively investigated by medical professionals in recent times. The book “Selenium: In Health And Diseases,” edited by Dr. Muhammed Majeed, Founder and Chairman of Sami-Sabinsa Group, delves into the chemistry, biochemistry, and biology of the selenium element in relation to human health.

The recent pandemic has put a spotlight on the need to maintain a healthy immune system, particularly in instances where there are limited therapeutic options. This has put selenium’s immune capability in the centre stage, which aids in reducing oxidative stress, inflammation, and disease pathogenesis as well as preventing viral infection and strengthening immunity.

The scientific publication underlines Selenium as an essential micronutrient for both human and animal health, albeit in a minuscule amount. “The book discusses the importance of selenium supplements in enhancing immunity, supporting a healthy thyroid, preserving gastrointestinal health, promoting reproductive function, aiding in cancer therapy, and enhancing skin and hair health,” said Dr. Muhammed Majeed, Chairman and Founder, Sami-Sabinsa Group.

The book also mentions various selenium products offered by Sami-Sabinsa Group, including PeptiSeLect®, MethySelene®, PeptiSelene®, Selendrovir®, ImmuActive®, Selenium Select®, and SelenoForce®. “Our clinical evaluation of ImmuActive®, a herbal and mineral supplement, demonstrates that it can effectively manage COVID-19 symptoms as an adjunct therapy,” Dr. Majeed added.

Copies of the book are currently available online at amazon and flipKart for purchase in India. Sami-Sabinsa Group Ltd. headquartered in Bangalore, is an Indian Multinational Health Science Company that is into the manufacture of nutraceuticals, cosmeceuticals, standardised herbal extracts, fine chemicals, speciality chemicals, and probiotics. With the preventive healthcare market gaining more prominence worldwide, Sami-Sabinsa Group has established its footprint in all major markets with products that are based on scientific evidence and clinical evaluations. Sami-Sabinsa Group is the largest exporter of natural nutraceuticals in India.

The post Sami-Sabinsa Group releases book on Selenium in Health and Diseases appeared first on Health Vision.

Mr. Ramana Rao, CFO, Sami-Sabinsa Group Ltd (second from left) receives the “Best Manufacturer Export Award 2022” from Dr. Murugesh R. Nirani, Hon’ble Minister for Large & Medium Scale Industries, Govt. of Karnataka (centre). Seen along with is Dr. E.V. Ramana Reddy, IAS, Additional Chief Secretary to Dept. of Industries & Commerce, Govt. of Karnataka (extreme left); Dr. CA I S Prasad (Second from Right), President, FKCCI; Mr. B.V.Gopal Reddy, President-Elect (Right)

Bengaluru September 24: Sami-Sabinsa Group, the multi-national health science company that is into manufacture of nutraceuticals, cosmeceuticals, standardised herbal extracts, fine chemicals, specialty chemicals, and probiotics, is honoured with the “Best Manufacturer Export Award 2022” by the Federation of Karnataka Chambers of Commerce and Industry (FKCCI) in Bengaluru on September 21, 2022.

Sami-Sabinsa bagged the top honours in the “Medium Category” of exports. The award was presented by Dr. Murugesh R. Nirani, Hon’ble Minister for Large & Medium Scale Industries, Govt. of Karnataka. Mr. Ramana Rao, CFO, Sami-Sabinsa Group, accepted the award in presence of Dr. E.V. Ramana Reddy, IAS, Additional Chief Secretary to Dept. of Industries & Commerce, Govt. of Karnataka, Dr. CA I S Prasad (Second from Right), President, FKCCI, Mr. B.V.Gopal Reddy, President-Elect (Right) and a host of other dignitaries.

The Export Excellence Award is a flagship event organised by FKCCI every year wherein the exporters of Karnataka in various categories at both the State and District levels are recognised and the best performers are felicitated.

Expressing his pleasure over the distinction, Dr. Muhammed Majeed, Founder and Chairman, Sami-Sabinsa Group, said, “Recognitions like these give us a tremendous impetus to continue our journey towards becoming a global leader in nutraceutical exports. I thank the Government of Karnataka and FKCCI for their initiative in trying to recognize nutraceutical exports and specifically for choosing us for this award.

Also Read: Nutraceuticals for good health Article from Dr. Muhammed Majeed, Founder and Chairman, Sami-Sabinsa Group

The post Sami-Sabinsa Group honoured with the “Best Manufacturer Export Award 2022 appeared first on Health Vision.

It is common knowledge that the best source of nutrition for the body comes from the traditional foods such as fruits and vegetables made at home with great care and love. But over the past few decades, changes in the method of growing crops by using harmful chemicals and pesticides, artificial ripening of fruits and vegetables have depleted the nutritional values in our regular foods. Our body needs the daily dose of nutrition in the form of vitamins, minerals, proteins, carbohydrates, fats and other nutrients for it to sustain. While the result of a scarce supply of the required daily dose of nutrients to the body may not be seen immediately, it ultimately will manifest itself in the form of various ailments in the long run. The lack of nutrition coupled with lifestyle changes, improper eating habits, stress, pollution, shorter sleep cycles and the unhealthy foods that we consume today has led to the advent of many lifestyle disorders, the most common ones being obesity, diabetes and cardiovascular ailments to name a few.

Nutraceuticals play a prominent role in preventive healthcare:

These unwelcome changes have also had a significant bearing on medical expenses going through the roof. Keeping in line with the adage “Prevention is better than cure” nutraceuticals play a prominent role in preventive healthcare. Nutraceuticals are dietary supplements that have a good safety record and may compensate for a poor diet and / or promote health. They can be divided into various categories namely vitamins, minerals, protein supplements, energy drinks, probiotics and growth supplements. Nutritional care which forms an integral part of preventive healthcare is undergoing a transformation in India. The current generation is looking for preventive healthcare measures rather than remedial reactions. Due to higher disposable incomes and growing awareness about preventive healthcare, the Indian consumer is actively considering various options to improve his / her health and lifestyle.

Globally and in India the nutraceuticals segment has undergone its fair share of churn.  From a one-solution-fits-all scenario, the space has witnessed mushrooming of various products to address specific needs – bone health, calcium supplements, weight management, proteins and immunity boosters according to age, to name a few. Nutraceuticals can be broadly divided into:

1. Dietary supplements (including vitamins and minerals)

2. Functional foods and beverages (such as energy and sports drinks, probiotics, products fortified with omega-3 fatty acids and herbal formulations)

According to a joint study by The Associated Chambers of Commerce and Industry of India  (ASSOCHAM) in association with its knowledge partner RNCOS, the Indian nutraceutical market is poised to grow from $2.8 billion in 2015 to $8.5 billion by 2022. India which accounted for a share of around 2% of the global market in 2015 is estimated to increase its share of market to 3% by 2022 owing to the country’s large population base, increasing urban belt and increasing awareness, according to the study. Functional food & beverages are expected to grow with a higher growth rate due to the increasing visibility of such products in modern retail formats and promotional activities.

Few key drivers for growth of nutraceuticals in India :

1. Increased awareness – Growing concerns about nutrition and health thanks to digitization and social media has led consumers to look for preventive healthcare measures

2. Affordability – High hospitalization costs and complex medical procedures which can be avoided are driving consumers towards health supplements and nutraceuticals

3. Increase in lifestyle diseases – Stress factors due to a busy lifestyle which leads to changing dietary patterns has led people to look for alternative food supplements to enhance their health

4. Inferior food quality – The lack of nutritious food has made people to turn to nutritional supplements to meet their dietary requirements and protect against nutritional deficiencies.

5. Healthy appearance- Looking and feeling good is another significant driver for the nutraceuticals space to witness a robust growth. Body weight, hair growth and a glowing skin are top priorities for today’s consumer. Remedial cost far outstrips preventive measures and this is where nutraceuticals comes in.

Key challenges faced by nutraceuticals segment in India :

Lack of a clear regulatory framework which has been a major challenge to the growth and wide spread acceptance of nutraceuticals as a segment in India. Counterfeit products which are unregistered and unapproved has led to scepticism and lack of trust from consumers as well as within the industry trade community In the past urban India, or more precisely the metros, were the target markets for nutraceutical sales, but consumption patterns have witnessed a shift with a steady increase in demand from Tier II and Tier III cities. This trend will only gather momentum especially because of the large-scale digitization happening in India. To sum up, this is one of the most exciting times to be part of the nutraceutical industry with new players entering the market and rapid innovation happening within the industry.

Dr. Muhammed Majeed

Sami-Sabinsa Group’s Founder & Chairman

The post Nutraceuticals for good health appeared first on Health Vision.

Bengaluru,March 09 2020: Sami-Sabinsa Group, a pioneer and global leader in health science, was honoured with three awards by the Associated Chambers of Commerce and Industry of India (ASSOCHAM) at the 3^rd edition of their Beauty, Wellness and Personal Care Awards held in New Delhi on February 28, 2020.

ASSOCHAM acknowledged Sami-Sabinsa Group’s Founder & Chairman, Dr. Muhammed Majeed, for his immense contribution towards shaping the Indian Cosmeceutical industry by presenting him with the “Legend of Natural Cosmeceuticals” award. In addition, the Group received accolades for “Best Personal Care Product of the Year 2020” for its premium beauty product – Johara^® Turmeric Bath Soap and “Best Cosmetic Ingredient Manufacturer of the Year” for Sami Labs Limited (a part of Sami-Sabinsa Group).

Commenting on the personal recognition, Dr. Majeed said, “It’s a tremendous honour to receive this award from ASSOCHAM. The Ayurveda-based approach to cosmetics has inspired formulas containing herbs and other natural ingredients that form an integral part of daily skin care regimens. Highly regarded and valued, these products reaffirm the vast knowledge of the ancient Indian traditional system of medicine by providing excellent results. Johara is a scientifically-driven brand crafted from years of meticulous research and utilizing time-tested botanical ingredients.”

 The Sami-Sabinsa Group was previously honoured by ASSOCHAM in 2018 with the “Excellence Award for Best Raw Material / Ingredient Supplier,” and the Johara Cosmetics division with the “Excellence Award for Best Cosmetics Company” at the organization’s second edition event held in New Delhi.

ASSOCHAM’s Beauty, Wellness and Personal Care Awards celebrates those who have consistently met the unique beauty and wellness needs of multicultural Indians. The star-studded event recognizes individuals, organizations, and brands that have achieved excellence in the field of cosmetics, wellness, and personal care. ASSOCHAM is one of the apex trade associations of India, having in its fold more than 250 Chambers and Trade Associations and serving more than 450,000 members from across India. It has contributed significantly by playing a catalytic role in shaping the Trade, Commerce, and Industrial environment of the country.

 About Sami-Sabinsa Group:

ASSOCHAM honours Dr Muhammed Majeed. Sami-Sabinsa Group, a pioneer and global leader in health science, is a leading producer of nutraceuticals, cosmeceuticals, standardized herbal extracts, fine chemicals, specialty chemicals, and probiotics. Founded in 1988 by Dr. Muhammed Majeed, an internationally acclaimed scientist turned entrepreneur in the field of Alternative Medicine, the Group has independent research divisions including Natural Drugs, Phytochemistry, Synthetic Chemistry, Tissue Culture, Biotechnology, Analytical R&D, Biological Research, Microbiology, and Formulations R&D, all of which coordinate in a synergistic work model to create products meeting international standards.

Sami-Sabinsa, under the visionary leadership of Dr. Majeed has pioneered the contract farming model deploying close to 40,000 acres of land, demonstrating its commitment to sustainable development. A team of 120 research scientists works tirelessly to discover and develop standardized natural extracts that render alternative therapy to emerging nutritional and health requirements across the globe. The Group has a sizeable patent portfolio comprising over 240 granted patents and 290+ pending patent applications worldwide.

For more information: samilabs.com

The post ASSOCHAM honours Dr. Muhammed Majeed appeared first on Health Vision.

Sami-Sabinsa Group has announced the launch of its new manufacturing facility in Hassan, Karnataka at an Investment of Rs. 200 Crore. First phase of plant will be functional in 2021 and is part of Sami-Sabinsa Group’s strategy to expand existing ingredient growth and focus on new innovative products.

A pioneerand global leader in health science and nutraceuticals, Sami-Sabinsa Group has announced the launch of its new manufacturing facility at Pharma SEZ Industrial Area, Hassan, Karnataka.  The first phase of the plant will house a 40,000 square metres world-class Active Nutraceutical Ingredients (ANI) manufacturing unit, with anannual capacity of 300 tons and will be functional by 2021. The new facility with a planned investment of Rs. 200 crore is part of the Sami-Sabinsa Group’s growth strategy.

Founder & Chairman, Sami-Sabinsa Group Dr. Muhammed Majeed, says “World over, consumers are seeking alternatives to better health and looking for food and beverages that supply all their nutritional needs. As the pioneer and among the few Indian companies to have created a global market for patented formulations in the health space, we are committed to a research-oriented, science-based approach towards developing products that make lives healthier and better. The upcoming facility at Hassan, is a reinforcement of this commitment. The new unit when operational will play a pivotal role in boosting our exports further and help us to double our revenues. The first phase, once functional in 2021, will provide employment to around 400 qualified workforce in the fast-growing industrial region of Hassan”.

Mr. V.G Nair, Director and CEO, Sami-Sabinsa Group added, “Sami-Sabinsa’s new plant is designed to be world-class, meeting international standards & requirements and will house a high quality, environment-friendly Zero Liquid Discharge (ZLD) facility ensuring energy efficiency, responsible water management and biodiversity development. The ANI facility is 100% cGMP and regulatory compliant”.

The Hassan plant is Sami-Sabinsa Group’s sixth global manufacturing facility, in addition to its current units located in Peenya, Dobaspet, Kunigal, Hyderabad, Nelamangala and USA. When fully functional, the new plant will not only expand the Group’s overall manufacturing capacity but also strengthen Sami-Sabinsa Group’s ranking as among India’s foremost and largest global nutraceuticals major.

According to latest industry reports, the global market for nutraceuticals is set for robust growth. It is expected to reach $373 billion by 2025, growing at a CAGR of 7.5%, as per PMMI Business Intelligence report. The Indian nutraceuticals market has flourished to a $3 billion industry and is forecast to touch $8.1 billion by 2022.

About Sami-Sabinsa Group:

Sami-Sabinsa Group, a pioneer and global leader in health science and nutraceuticals, is a leading producer ofnutraceuticals, cosmeceuticals, standardised herbal extracts, fine chemicals, specialty chemicals and probiotics. Founded in 1988 by Dr. Muhammed Majeed, an internationally acclaimed scientist turned entrepreneur in the field of Alternative Medicine, the Group has independent research divisions including Natural drugs, Phytochemistry, Synthetic Chemistry, Tissue Culture, Biotechnology, Analytical R&D, Biological Research, Microbiology and Formulations R&D, all of which coordinate in a synergistic work model to create products meeting international standards.

Sami-Sabinsa Group under the visionary leadership of Dr. Majeed also pioneered the contract farming model deploying close to 40,000 acres of land, demonstrating its commitment to sustainable development. A team of 120 research scientists work tirelessly to discover and develop standardized natural extracts that render alternative therapy to emerging nutritional and health requirements across the globe.

For more information visit samilabs.com.

Other pharma related articles visit Pharma section

The post Sami-Sabinsa Group to launch new manufacturing facility in Hassan appeared first on Health Vision.